Who owns nChroma (formerly Chroma Medicine)?

nChroma (formerly Chroma Medicine) is currently owned by Sofinnova Partners, through Sofinnova Telethon, since 2022.

When did Sofinnova Partners acquire nChroma (formerly Chroma Medicine)?

Sofinnova Partners acquired nChroma (formerly Chroma Medicine) in 2022 (active for 4 years).

Home/Companies/Biotech/nChroma (formerly Chroma Medicine)

nChroma (formerly Chroma Medicine)

Biotech·

US·Active·4yr hold

nChroma (formerly Chroma Medicine) is a healthcare / biotech company, headquartered in United States.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited States

SectorHealthcare / Biotech

US company developing epigenetic therapies using stable and long-lasting gene silencing technology for genetic diseases.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Telethon

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings